,,iii #aag? ,,congress #a/ ,session ,s4 ,,res4 #djj ,,9 ,,! ,,s5ate ,,( ,,! ,,unit$ ,,/ates ,septemb] #cj1 #bjba,mr4 ,man*9 7= himself1 ,mr4 ,scott ( ,s\? ,c>ol9a1 ,mr4 ,re$1 ,mrs4 ,capito1 ,mr4 ,casey1 ,mr4 ,graham1 & ,mr4 ,hawley7 submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ! ,judici>y ,,resolution ,designat+ ,septemb] #bjba z ,national ,*ildhood ,canc] ,aw>5ess ,mon?4 ,:]eas ea* ye> m ?an #ae1ejj *ildr5 "u ! age ( #ai 9 ! ,unit$ ,/ates are diagnos$ ) canc]2 ,:]eas e ye> m ?an #a1gjj *ildr5 9 ! ,unit$ ,/ates lose _! lives to canc]2 ,:]eas *ildhood canc] is ! lead+ cause ( dea? f disease & ! second ov]all lead+ cause ( dea? = *ildr5 9 ! ,unit$ ,/ates2 ,:]eas ! #e-ye> survival rate = *ildr5 ) canc] has increas$ f #eh p]c5t 9 ! mid-#aigjs to #hd p]c5t 9 #bjbj1 repres5t+ significant improvem5t f previ\s decades2 ,:]eas m ?an #b_/c ( *ildr5 :o survive canc] w develop at lea/ #a *ronic heal? condition1 & _m survivors w face a late-effect f treatm5t t c\ld be consid]$ sev]e or life-?reat5+2 ,:]eas canc] pati5ts face a high] risk ( contract+ ! ,coronavirus ,disease #bjai 7,,covid-#ai7 due to weak5$ immune sy/ems2 & ,:]eas canc] occurs regul>ly & r&omly & sp>es no racial or e?nic gr\p1 socioeconomic class1 or geographic region3 ,n[1 !re=e1 be x ,t ! ,s5ate-- 7#a7 designates ,septemb] #bjba z ,national ,*ildhood ,canc] ,aw>5ess ,mon?2 7#b7 reque/s t ! ,f$]al ,gov]nm5t1 ,/ates1 localities1 & nonpr(it organizations obs]ve ! mon? ) appropriate programs & activities1 ) ! goal ( increas+ public k ( ! risks ( canc]2 7#c7 enc\rages survivors ( *ildhood canc] to cont9ue to receive ongo+ monitor+ & physical & psy*osocial c>e ?r\gh\t _! adult lives2 7#d7 recognizes ! human toll ( canc] & pl$ges to make ! prev5tion & cure ( canc] a public heal? priority2 & 7#e7 rem9ds ! p ( ! ,unit$ ,/ates t ^! *ildr5 are ! def9ition ( brav]y1 & comm5ds & honors _! c\rage4